Skip to main content

Table 4 Occurrence of haematuria at baseline and 2 years after praziquantel treatment

From: Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity

 

Before Treatment

 

2 years Post treatment

 
 

S. haematobium

Infected

S. haematobium

Uninfected

S. haematobium

Infected

S. haematobium

Uninfected

Boys

9 (45%)

5 (5.9%)

0

0

Girls

14 (48.3%)

4 (5.1%)

0

0

7–9

8 (42.1%)

3 (3.9%)

0

0

10–13

15 (50%)

6 (6.9%)

0

0